Carregant...
Update on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsy
Eslicarbazepine acetate (ESL) is a once daily new third generation antiepileptic drug that shares the basic chemical structure of carbamazepine and oxcarbazepine – a dibenzazepine nucleus with the 5-carboxamide substituent, but is structurally different at the 10,11-position. ESL is a pro-drug metab...
Guardat en:
| Publicat a: | Neuropsychiatr Dis Treat |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4889089/ https://ncbi.nlm.nih.gov/pubmed/27307737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S86765 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|